Perrigo adds cherry-flavored cetirizine
This article was originally published in The Tan Sheet
Executive SummaryFDA approves the private labeler's application to manufacture and market Cetirizine Cherry Syrup, 1 mg/mL - equivalent to Johnson & Johnson/McNeil's Zyrtec Children's Allergy Syrup. Perrigo's store-brand antihistamine will begin shipping to retailers by September, joining its current grape-flavored cetirizine syrup, Perrigo said July 26. The FDA approval is a good sign for Perrigo, as the application originated from the firm's Allegan, Mich., plant that elicited a warning letter in April due to quality system failings, Collins Stewart analyst Louise Chen said in a same-day note (1"The Tan Sheet" June 21, 2010). "We think that the FDA would not have approved a product out of Michigan if the agency felt there were substantive manufacturing issues at the facility," Chen wrote
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.